Global and United States Gastrointestinal Drugs Market Report & Forecast 2022-2028

Global and United States Gastrointestinal Drugs Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Gastrointestinal Drugs Product Introduction
1.2 Global Gastrointestinal Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Gastrointestinal Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Gastrointestinal Drugs Sales in Volume for the Year 2017-2028
1.3 United States Gastrointestinal Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Gastrointestinal Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Gastrointestinal Drugs Sales in Volume for the Year 2017-2028
1.4 Gastrointestinal Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Gastrointestinal Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Gastrointestinal Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Gastrointestinal Drugs Market Dynamics
1.5.1 Gastrointestinal Drugs Industry Trends
1.5.2 Gastrointestinal Drugs Market Drivers
1.5.3 Gastrointestinal Drugs Market Challenges
1.5.4 Gastrointestinal Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Gastrointestinal Drugs Market Segment by Type
2.1.1 Prescription Gastrointestinal Drug
2.1.2 OTC Gastrointestinal Drug
2.2 Global Gastrointestinal Drugs Market Size by Type
2.2.1 Global Gastrointestinal Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Gastrointestinal Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Gastrointestinal Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Gastrointestinal Drugs Market Size by Type
2.3.1 United States Gastrointestinal Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Gastrointestinal Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Gastrointestinal Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Gastrointestinal Drugs Market Segment by Application
3.1.1 Chronic Gastritis
3.1.2 Functional Dyspepsia
3.1.3 Peptic Ulcer
3.1.4 Acute Gastroenteritis
3.1.5 Other
3.2 Global Gastrointestinal Drugs Market Size by Application
3.2.1 Global Gastrointestinal Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Gastrointestinal Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Gastrointestinal Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Gastrointestinal Drugs Market Size by Application
3.3.1 United States Gastrointestinal Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Gastrointestinal Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Gastrointestinal Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Gastrointestinal Drugs Competitor Landscape by Company
4.1 Global Gastrointestinal Drugs Market Size by Company
4.1.1 Top Global Gastrointestinal Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Gastrointestinal Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Gastrointestinal Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Gastrointestinal Drugs Price by Manufacturer (2017-2022)
4.2 Global Gastrointestinal Drugs Concentration Ratio (CR)
4.2.1 Gastrointestinal Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Gastrointestinal Drugs in 2021
4.2.3 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gastrointestinal Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Gastrointestinal Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Gastrointestinal Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Gastrointestinal Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Gastrointestinal Drugs Market Size by Company
4.5.1 Top Gastrointestinal Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Gastrointestinal Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Gastrointestinal Drugs Sales by Players (2020, 2021 & 2022)
5 Global Gastrointestinal Drugs Market Size by Region
5.1 Global Gastrointestinal Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Gastrointestinal Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Gastrointestinal Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Gastrointestinal Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Gastrointestinal Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Gastrointestinal Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Gastrointestinal Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gastrointestinal Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Gastrointestinal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 the United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gastrointestinal Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Gastrointestinal Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Gastrointestinal Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Gastrointestinal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gastrointestinal Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Gastrointestinal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gastrointestinal Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporation Information
7.1.2 AstraZeneca Description and Business Overview
7.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 AstraZeneca Gastrointestinal Drugs Products Offered
7.1.5 AstraZeneca Recent Development
7.2 Sanofi
7.2.1 Sanofi Corporation Information
7.2.2 Sanofi Description and Business Overview
7.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Sanofi Gastrointestinal Drugs Products Offered
7.2.5 Sanofi Recent Development
7.3 Bayer
7.3.1 Bayer Corporation Information
7.3.2 Bayer Description and Business Overview
7.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bayer Gastrointestinal Drugs Products Offered
7.3.5 Bayer Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Gastrointestinal Drugs Products Offered
7.4.5 Pfizer Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporation Information
7.5.2 GlaxoSmithKline Description and Business Overview
7.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GlaxoSmithKline Gastrointestinal Drugs Products Offered
7.5.5 GlaxoSmithKline Recent Development
7.6 Teva
7.6.1 Teva Corporation Information
7.6.2 Teva Description and Business Overview
7.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Teva Gastrointestinal Drugs Products Offered
7.6.5 Teva Recent Development
7.7 Zeria (Tillotts)
7.7.1 Zeria (Tillotts) Corporation Information
7.7.2 Zeria (Tillotts) Description and Business Overview
7.7.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Zeria (Tillotts) Gastrointestinal Drugs Products Offered
7.7.5 Zeria (Tillotts) Recent Development
7.8 Perrigo
7.8.1 Perrigo Corporation Information
7.8.2 Perrigo Description and Business Overview
7.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Perrigo Gastrointestinal Drugs Products Offered
7.8.5 Perrigo Recent Development
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Corporation Information
7.9.2 Boehringer Ingelheim Description and Business Overview
7.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Boehringer Ingelheim Gastrointestinal Drugs Products Offered
7.9.5 Boehringer Ingelheim Recent Development
7.10 Purdue Pharma
7.10.1 Purdue Pharma Corporation Information
7.10.2 Purdue Pharma Description and Business Overview
7.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Purdue Pharma Gastrointestinal Drugs Products Offered
7.10.5 Purdue Pharma Recent Development
7.11 C.B. Fleet
7.11.1 C.B. Fleet Corporation Information
7.11.2 C.B. Fleet Description and Business Overview
7.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 C.B. Fleet Gastrointestinal Drugs Products Offered
7.11.5 C.B. Fleet Recent Development
7.12 Abbott
7.12.1 Abbott Corporation Information
7.12.2 Abbott Description and Business Overview
7.12.3 Abbott Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Abbott Products Offered
7.12.5 Abbott Recent Development
7.13 Jiangzhong
7.13.1 Jiangzhong Corporation Information
7.13.2 Jiangzhong Description and Business Overview
7.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Jiangzhong Products Offered
7.13.5 Jiangzhong Recent Development
7.14 Xian-Janssen
7.14.1 Xian-Janssen Corporation Information
7.14.2 Xian-Janssen Description and Business Overview
7.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Xian-Janssen Products Offered
7.14.5 Xian-Janssen Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Gastrointestinal Drugs Industry Chain Analysis
8.2 Gastrointestinal Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Gastrointestinal Drugs Distributors
8.3 Gastrointestinal Drugs Production Mode & Process
8.4 Gastrointestinal Drugs Sales and Marketing
8.4.1 Gastrointestinal Drugs Sales Channels
8.4.2 Gastrointestinal Drugs Distributors
8.5 Gastrointestinal Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Gastrointestinal Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Gastrointestinal Drugs Market Trends
Table 3. Gastrointestinal Drugs Market Drivers
Table 4. Gastrointestinal Drugs Market Challenges
Table 5. Gastrointestinal Drugs Market Restraints
Table 6. Global Gastrointestinal Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Gastrointestinal Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Gastrointestinal Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Gastrointestinal Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Gastrointestinal Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Gastrointestinal Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Gastrointestinal Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Gastrointestinal Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Gastrointestinal Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Gastrointestinal Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2021)
Table 18. Top Players of Gastrointestinal Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Gastrointestinal Drugs Product Type
Table 20. Date of International Manufacturers Enter into Gastrointestinal Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Gastrointestinal Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Gastrointestinal Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Gastrointestinal Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Gastrointestinal Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Gastrointestinal Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Gastrointestinal Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Gastrointestinal Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Gastrointestinal Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Gastrointestinal Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Gastrointestinal Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Gastrointestinal Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Gastrointestinal Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Gastrointestinal Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Gastrointestinal Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Gastrointestinal Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Gastrointestinal Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Gastrointestinal Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Gastrointestinal Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Gastrointestinal Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Gastrointestinal Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. AstraZeneca Corporation Information
Table 43. AstraZeneca Description and Business Overview
Table 44. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. AstraZeneca Gastrointestinal Drugs Product
Table 46. AstraZeneca Recent Development
Table 47. Sanofi Corporation Information
Table 48. Sanofi Description and Business Overview
Table 49. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Sanofi Product
Table 51. Sanofi Recent Development
Table 52. Bayer Corporation Information
Table 53. Bayer Description and Business Overview
Table 54. Bayer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Bayer Product
Table 56. Bayer Recent Development
Table 57. Pfizer Corporation Information
Table 58. Pfizer Description and Business Overview
Table 59. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Pfizer Product
Table 61. Pfizer Recent Development
Table 62. GlaxoSmithKline Corporation Information
Table 63. GlaxoSmithKline Description and Business Overview
Table 64. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. GlaxoSmithKline Product
Table 66. GlaxoSmithKline Recent Development
Table 67. Teva Corporation Information
Table 68. Teva Description and Business Overview
Table 69. Teva Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Teva Product
Table 71. Teva Recent Development
Table 72. Zeria (Tillotts) Corporation Information
Table 73. Zeria (Tillotts) Description and Business Overview
Table 74. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Zeria (Tillotts) Product
Table 76. Zeria (Tillotts) Recent Development
Table 77. Perrigo Corporation Information
Table 78. Perrigo Description and Business Overview
Table 79. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Perrigo Product
Table 81. Perrigo Recent Development
Table 82. Boehringer Ingelheim Corporation Information
Table 83. Boehringer Ingelheim Description and Business Overview
Table 84. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Boehringer Ingelheim Product
Table 86. Boehringer Ingelheim Recent Development
Table 87. Purdue Pharma Corporation Information
Table 88. Purdue Pharma Description and Business Overview
Table 89. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Purdue Pharma Product
Table 91. Purdue Pharma Recent Development
Table 92. C.B. Fleet Corporation Information
Table 93. C.B. Fleet Description and Business Overview
Table 94. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. C.B. Fleet Product
Table 96. C.B. Fleet Recent Development
Table 97. Abbott Corporation Information
Table 98. Abbott Description and Business Overview
Table 99. Abbott Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Abbott Product
Table 101. Abbott Recent Development
Table 102. Jiangzhong Corporation Information
Table 103. Jiangzhong Description and Business Overview
Table 104. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Jiangzhong Product
Table 106. Jiangzhong Recent Development
Table 107. Xian-Janssen Corporation Information
Table 108. Xian-Janssen Description and Business Overview
Table 109. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Xian-Janssen Product
Table 111. Xian-Janssen Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Gastrointestinal Drugs Customers List
Table 115. Gastrointestinal Drugs Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal Drugs Product Picture
Figure 2. Global Gastrointestinal Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Gastrointestinal Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Gastrointestinal Drugs Sales 2017-2028 (K Units)
Figure 5. United States Gastrointestinal Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Gastrointestinal Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Gastrointestinal Drugs Sales 2017-2028 (K Units)
Figure 8. United States Gastrointestinal Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Gastrointestinal Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Gastrointestinal Drugs Report Years Considered
Figure 11. Product Picture of Prescription Gastrointestinal Drug
Figure 12. Product Picture of OTC Gastrointestinal Drug
Figure 13. Global Gastrointestinal Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Gastrointestinal Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Gastrointestinal Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Gastrointestinal Drugs Sales by Type (2017-2028) & (K Units)
Figure 17. Global Gastrointestinal Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Gastrointestinal Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Gastrointestinal Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Gastrointestinal Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Gastrointestinal Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Gastrointestinal Drugs Sales by Type (2017-2028) & (K Units)
Figure 23. United States Gastrointestinal Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Gastrointestinal Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Chronic Gastritis
Figure 26. Product Picture of Functional Dyspepsia
Figure 27. Product Picture of Peptic Ulcer
Figure 28. Product Picture of Acute Gastroenteritis
Figure 29. Product Picture of Other
Figure 30. Global Gastrointestinal Drugs Market Share by Application in 2022 & 2028
Figure 31. Global Gastrointestinal Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Gastrointestinal Drugs Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Gastrointestinal Drugs Sales by Application (2017-2028) & (K Units)
Figure 34. Global Gastrointestinal Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Gastrointestinal Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Gastrointestinal Drugs Market Share by Application in 2022 & 2028
Figure 37. United States Gastrointestinal Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Gastrointestinal Drugs Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Gastrointestinal Drugs Sales by Application (2017-2028) & (K Units)
Figure 40. United States Gastrointestinal Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Gastrointestinal Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. the United States Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. UK Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. China Taiwan Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 65. Latin America Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Gastrointestinal Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 70. Middle East & Africa Gastrointestinal Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Gastrointestinal Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Gastrointestinal Drugs Value Chain
Figure 75. Gastrointestinal Drugs Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs